FDA Approves New Nonprescription Eye Drop for Relief of Eye Redness
Start here
The FDA approved Brytly, apraclonidine ophthalmic solution 0.125%, as the first nonprescription eye drop containing apraclonidine, for relief of eye redness due to minor irritations in adults and children 12 and older. The approval, granted to Alcon, limits use to no more than two times per day. It aligns with FDA priorities to expand access to affordable nonprescription medicines.
Excerpted from fda.gov
Coverage timeline
Follow the coverage to see the different angles.
- fda.govPickFDA Approves New Nonprescription Eye Drop for Relief of Eye Redness
The FDA approved Brytly, apraclonidine ophthalmic solution 0.125%, as the first nonprescription eye drop containing apraclonidine, for relief of eye redness due to minor irritations in adults and children 12 and older. The approval, granted to Alcon, limits use to no more than two times per day. It aligns with FDA priorities to expand access to affordable nonprescription medicines.
Heat trend for this story
Not enough continuous observation yet to draw a trend.